Posts Tagged ‘FTC’
Patient advocate: FTC opposition to Talecris takeover is "ridiculous"
Monday, June 1, 2009, 8:31 pm No Comments | Post a CommentA treatment for an inherited protein deficiency that causes lung and liver disease features prominently in the Federal Trade Commission’s request to block the $3.1 billion takeover of Talecris Biotherapeutics, one of the Research Triangle’s largest drugmakers.
